熱門資訊> 正文
    
 COSCIENS Bizerma重组董事会
 
        2025-05-31 05:24
      
  
 
 
  - COSCIENS Biopharma (NASDAQ:CSCI) announced that Peter Puccetti has been appointed Board Chair; key board committees have also been restructured.
- Source: Press release 
 
  More on COSCIENS Biopharma Inc.
 
   
   - Financial information for COSCIENS Biopharma Inc.
 
    風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。